Kestra Medical Technologies, Ltd. reported $107M of revenue over the trailing twelve months, +61% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $107M (to Q1 2027). Net income: −$150M, trailing twelve months to Q1 2027. Free cash flow: −$123M, trailing twelve months to Q1 2027. Operating margin: −135%, trailing twelve months to Q1 2027.

KMTSKestra Medical Technologies, Ltd.

Healthcare

$26.95+8.0% 1Y

$26.95

$17.8752 weeks$28.44

KMTS as reported

Kestra Medical Technologies, Ltd. reported $107M of revenue over the trailing twelve months, +61% on the year before. 10 reported series are charted on this page, each one as filed.

$107M

Revenue, trailing twelve months · to Q1 2027 · +61% against the twelve months before

Net income: −$150M
Net income · +25% year on year · trailing twelve months to Q1 2027
Free cash flow: −$123M
Free cash flow · +11% year on year · trailing twelve months to Q1 2027
Operating margin: −135%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for KMTS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$107M	+61%	Q1 2027
Net income	−$150M	+25%	Q1 2027
EPS	−$2.67	−41%	Q1 2027
Gross margin	54%	n/a	Q1 2027
Operating margin	−135%	n/a	Q1 2027
Net margin	−141%	n/a	Q1 2027
ROE	−62%	n/a	Q1 2027
ROA	−43%	n/a	Q1 2027
ROIC	−211%	n/a	Q1 2027
Free cash flow	−$123M	+11%	Q1 2027

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.